# Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma

> **NCT01623921** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Blunt Chest Trauma
- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** standard care treatment
- **DRUG:** Celecoxib
- **DRUG:** Rosuvastatin
- **DRUG:** Combined therapy

## Key facts

- **NCT ID:** NCT01623921
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01623921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01623921, "Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest Trauma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01623921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*